Skip to main content

Featured Post

AMD to invest $400 million in India by 2028: Here’s what we know

US chipmaker Advanced Micro Devices said on Friday it will invest around $400 million in India over the next five years and will build its largest design center in the tech hub of Bengaluru. AMD’s announcement was made by its Chief Technology Officer Mark Papermaster at an annual semiconductor conference that started Friday in Prime Minister Narendra Modi’s home state of Gujarat. Other speakers at the flagship event include Foxconn Chairman Young Liu and Micron CEO Sanjay Mehrotra. Despite being a late entrant, the Modi government has been courting investments into India’s nascent chip sector to establish its credentials as a chipmaking hub. AMD said it will open its new design centre campus in Bengaluru by end of this year and create 3,000 new engineering roles within five years. “Our India teams will continue to play a pivotal role in delivering the high-performance and adaptive solutions that support AMD customers worldwide,” Papermaster said. The new 500,000-square-foot (55,5...

AI platform market for healthcare industry to reach $4.3 bn in 2024: Report

The market for Artificial Intelligence (AI) platforms for the entire healthcare industry is set to grow to $4.3 billion in 2024 from $1.5 billion in 2019, according to a new report. This is owing to the added integration of digital health tools and technologies such as AI and Machine Learning (ML) into the healthcare industry due to the impact of the Covid-19 pandemic, said the report by GlobalData, a data and analytics company.

Various healthcare companies are already implementing high-tech solutions into existing healthcare systems. French biotechnology company Genomic Vision, which specialises in the development and commercialisation of diagnostic solutions for genetic diseases and cancers, has recently launched FiberSmart, a new technology that enables the visualisation and analysis of long DNA fibres at high resolution.

Genomic Vision claims that FiberSmart has the potential to improve the accuracy and efficiency of genetic disease diagnosis and treatment, leading to better patient outcomes and reduced healthcare costs.

“The integration of digital health tools and technologies such as AI and ML to analyse large amounts of data and identify patterns and insights is transforming the healthcare industry and paving the way for more personalised and efficient healthcare,” Kamilla Kan, Medical Analyst at GlobalData, said in a statement.

Furthermore, AI is being used to improve the accuracy and efficiency of diagnoses, identify new treatments and therapies, and even predict and prevent disease outbreaks.

“The growing market for AI platforms in healthcare reflects the increasing demand for innovative solutions that can improve patient outcomes and reduce costs,” Kan said.

–IANS

The post AI platform market for healthcare industry to reach $4.3 bn in 2024: Report appeared first on Techlusive.



from Techlusive https://ift.tt/RSHEdt2
via IFTTT

Comments